These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18523989)

  • 21. HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling.
    Martin PJ; Gooley T; Anasetti C; Petersdorf EW; Hansen JA
    Biol Blood Marrow Transplant; 1998; 4(3):128-33. PubMed ID: 9923410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
    Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease.
    Facon T; Jouet JP; Noel-Walter MP; Bloget F; Bauters F; Janin A
    Bone Marrow Transplant; 1997 Sep; 20(6):511-5. PubMed ID: 9313887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency.
    Engel ME; Hickstein DD; Bauer TR; Calder C; Manes B; Frangoul H
    Bone Marrow Transplant; 2006 Apr; 37(7):717-8. PubMed ID: 16489359
    [No Abstract]   [Full Text] [Related]  

  • 26. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.
    Saad AG; Alyea EP; Wen PY; Degirolami U; Kesari S
    J Clin Oncol; 2009 Oct; 27(30):e147-9. PubMed ID: 19667266
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood and marrow transplantation in the People's Republic of China.
    Wu T; Lu DP
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S73-S75. PubMed ID: 18724310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
    Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
    Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid analysis of tumor necrosis factor-alpha mRNA expression during venoocclusive disease of the liver after allogeneic bone marrow transplantation.
    Tanaka J; Imamura M; Kasai M; Masauzi N; Watanabe M; Matsuura A; Morii K; Kiyama Y; Naohara T; Higa T
    Transplantation; 1993 Feb; 55(2):430-2. PubMed ID: 8434396
    [No Abstract]   [Full Text] [Related]  

  • 31. Pure white cell aplasia (PWCA) relapsing after allogeneic BMT and successfully treated with nine DLIs.
    Marmont AM; Dominietto A; Gualandi F; Piaggio G; van Lint MT; Bacigalupo A
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):987-9. PubMed ID: 16920566
    [No Abstract]   [Full Text] [Related]  

  • 32. Isolated testicular and bone relapse in children with acute myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT.
    Yildirim I; Uçkan D; Cetin M; Tuncer M; Tezcan I
    Turk J Pediatr; 2007; 49(2):206-9. PubMed ID: 17907524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfusion-associated graft-versus-host disease.
    Rühl H; Bein G; Sachs UJ
    Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral basal ganglial necrosis after allogeneic bone marrow transplantation in a child with Kostmann syndrome.
    Suga N; Nagatoshi Y; Gondou K; Kira R; Ikuno Y; Okamura J
    Bone Marrow Transplant; 1999 Mar; 23(5):515-7. PubMed ID: 10100568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors].
    Hyo R; Taguchi J; Kamijo A; Tanaka M; Hashimoto C; Kanamori H; Motomura S; Maruta A; Ishigatsubo Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1845-9. PubMed ID: 19920386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparable outcomes of HLA-matched unrelated and HLA-identical sibling donor bone marrow transplantation for childhood acute myeloid leukemia in first remission.
    Lee DH; Kwon YJ; Lim J; Kim Y; Han K; Chung NG; Jeong DC; Cho B; Kim HK
    Pediatr Transplant; 2009 Mar; 13(2):210-6. PubMed ID: 18627512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting.
    Alcoceba M; Balanzategui A; Díez-Campelo M; Martín-Jiménez P; Sarasquete ME; Chillón MC; Santamaría C; Pérez-Simón JA; Marín L; Caballero MD; San Miguel JF; García-Sanz R; González M
    Transplantation; 2008 Oct; 86(7):983-90. PubMed ID: 18852666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.